🔆 📖 👤

Statutory Instruments

2017 No. 207

Consumer Protection

The Medical Devices (Fees Amendment) Regulations 2017

Made

24th February 2017

Laid before Parliament

2nd March 2017

Coming into force

1st April 2017

The Secretary of State makes these Regulations in exercise of the powers conferred by section 2(2) of the European Communities Act 1972( 1 ) and section 56(1) and (2) of the Finance Act 1973( 2 ).

The Secretary of State has been designated for the purpose of section 2(2) of the European Communities Act 1972 in relation to medical devices( 3 ).

The Treasury has consented to the making of these Regulations as required by section 56(1) of the Finance Act 1973.

Citation, commencement and interpretation

1. —(1) These Regulations may be cited as the Medical Devices (Fees Amendment) Regulations 2017 and shall come into force on 1st April 2017.

(2) In these Regulations, “the 2002 Regulations” means the Medical Devices Regulations 2002( 4 ).

Amendment of regulation 53 of the 2002 Regulations

2. In regulation 53 of the 2002 Regulations (fees in connection with the registration of devices and changes to registration details), for “£70” substitute “£100”.

Amendment of regulation 54 of the 2002 Regulations

3. —(1) Regulation 54 of the 2002 Regulations (fees payable in connection with the designation etc. of UK notified bodies) is amended as follows.

(2) In paragraph (1)—

(a) in sub-paragraph (a), for “£960” substitute “£2,063”; and

(b) in sub-paragraph (b), for “£3,840”substitute “£8,252”.

(3) In paragraph (2), for “£1,880” substitute “£6,504”.

(4) In paragraph (3)—

(a) in sub-paragraph (a), for “£4,670” substitute “£15,904”;

(b) in sub-paragraph (b), for each of “£7,670”, “£5,760” and “£3,840” substitute “£10,160”; and

(c) in sub-paragraph (c), for “£3,840” substitute “£4,404”.

(5) In paragraph (3A)—

(a) in sub-paragraph (a)(i), for “£271” substitute “£361.20”; and

(b) in sub-paragraph (a)(ii), for “£75.24” substitute “£90.30”.

(6) After paragraph (3B) insert—

(3C) A UK notified body that applies to the Secretary of State for a renewal of its designation pursuant to article 4 of Regulation ( EU ) No 920/2013 shall pay to the Secretary of State—

(a) a fee of £8,252 in respect of the application; and

(b) where an audit is carried out in connection with the application, a fee of £15,904 in respect of the audit.

(3D) Where the Secretary of State conducts an assessment of a UK notified body pursuant to article 5 of Regulation (EU) No 920/2013, the UK notified body shall pay to the Secretary of State—

(a) if the assessment relates to the UK notified body’s assessment of clinical data only, a fee of £2,586; or

(b) in any other case, a fee of £3,876.

(3E) A UK notified body that submits a summary evaluation report to the Secretary of State pursuant to article 5(4) of Regulation (EU) No 722/2012 shall pay to the Secretary of State a fee of £532. .

(7) In paragraph (4)—

(a) in sub-paragraph (a)—

(i) for “regulation 45(1) or” substitute “regulation 45(1),”,

(ii) after “regulation 45(4)” insert “, a renewal under Regulation (EU) No 920/2013 (but not any associated audit) or a submission of a summary evaluation report under Regulation (EU) No 722/2012”, and

(iii) in paragraphs (i) and (ii), after “application” insert “or submission”; and

(b) in sub-paragraph (b), after “regulation 45(7)” insert “or an audit or assessment pursuant to Regulation (EU) No 920/2013”.

(8) After paragraph (4), insert—

(5) In this regulation, “Regulation (EU) No 920/2013” means Commission Implementing Regulation (EU) No 920/2013 of 24 September 2013 on the designation and the supervision of notified bodies under Council Directive 90/385/EEC on active implantable medical devices and Council Directive 93/42/EEC on medical devices ( 5 ) . .

Amendment of regulation 55 of the 2002 Regulations

4. —(1) Regulation 55 of the 2002 Regulations (fees payable in connection with the designation etc. of EC conformity assessment bodies) is amended as follows.

(2) In paragraph (1)—

(a) in sub-paragraph (a), for “£960” substitute “£2,063”; and

(b) in sub-paragraph (b), for “£3,840”substitute “£8,252”.

(3) In paragraph (2), for “£1,880” substitute “£6,504”.

(4) In paragraph (3)—

(a) in sub-paragraph (a), for “£4,670” substitute “£15,904”;

(b) in sub-paragraph (b), for “£3,840” substitute “£4,404”; and

(c) in sub-paragraph (d), for “£3,840” substitute “£4,404”.

(5) In paragraph (3A), for “£4,670” substitute “£15,904”.

(6) In paragraph (3B), for “£3,840” substitute “£4,404”.

(7) In paragraph (3D)—

(a) in sub-paragraph (a)(i), for “£271” substitute “£361.20”; and

(b) in sub-paragraph (a)(ii), for “£75.24” substitute “£90.30”.

Amendment of regulation 56 of the 2002 Regulations

5. —(1) Regulation 56 of the 2002 Regulations (fees payable in relation to clinical investigation notices) is amended as follows.

(2) In paragraph (2), after “paragraph (3)” insert “or (3A)”.

(3) After paragraph (3) insert—

(3A) Any person who submits an amendment to a notice of the supply of a device for the purposes of a clinical investigation under regulation 16(1) or 29(1) shall pay to the Secretary of State—

(a) a fee, if the device is a Group A device, of £207; or

(b) a fee, if the device is a Group B device, of £331. .

Signed by authority of the Secretary of State for Health.

O’Shaughnessy

Parliamentary Under-Secretary of State

Department of Health

23rd February 2017

We consent

Guto Bebb

Robert Syms

Two of the Lords Commissioners of Her Majesty’s Treasury

24th February 2017

( 1 )

1972 c.68 . Section 2(2) was amended by section 27(1)(a) of the Legislative and Regulatory Reform Act 2006 (c.51) and section 3(3) of, and Part 1 of the Schedule to, the European Union (Amendment) Act 2008 (c.7) . Under section 57(1) of the Scotland Act 1998 (c.46) , despite the transfer to Scottish Ministers of functions in relation to implementing obligations under European Union law in relation to devolved matters, the functions of the Secretary of State in relation to implementing these obligations continues to be exercisable by the Secretary of State as regards Scotland.

( 2 )

1973 c.51 . Section 56(1) was amended by article 6(1)(e) of the Treaty of Lisbon (Changes of Terminology) Order 2011 ( S.I. 2011/1043 ).

( 3 )

The Secretary of State was designated in relation to measures relating to active implantable medical devices in S.I. 1991/2289 and in relation to measures relating to medical devices other than active implantable medical devices in S.I. 1993/2661 .

( 5 )

OJ No L 253 25.9.2013 p.8.

Status: This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
The Medical Devices (Fees Amendment) Regulations 2017 (2017/207)

Displaying information

Status of this instrument

footnotecommentarytransitional and savingsin force statusrelated provisionsgeo extentinsert/omitsource countin force adj
Defined TermSection/ArticleIDScope of Application
the 2002 Regulationsreg. 1.the_2002_R_rtNv0y2

Status of changes to instrument text

The list includes made instruments, both those in force and those yet to come into force. Typically, instruments that are not yet in force (hence their changes are not incorporated into the text above) are indicated by description 'not yet' in the changes made column.